Abstract. The purpose of the present study was to identify genetic variants that confer susceptibility to chronic kidney disease (CKD) in individuals with low or high serum concentrations of triglycerides (TG), high-density lipoprotein (HDL)-cholesterol, or low-density lipoprotein (LDL)-cholesterol, thereby contributing to the personalized prevention of CKD in such individuals. The study population comprised 5944 Japanese individuals, including 1706 subjects with CKD [estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m 2 ] and 4238 controls (eGFR ≥60 ml/ min/1.73 m 2 ). The genotypes for 296 polymorphisms of 202 candidate genes were determined. The Chi-square test, multivariable logistic regression analysis with adjustment for covariates, and a stepwise forward selection procedure revealed that seven different polymorphisms were significantly (P<0.005) associated with the prevalence of CKD in individuals with low or high serum concentrations of TG or HDL-or LDL-cholesterol: the A→G (Glu23Lys) polymorphism of KCNJ11 and the 125592C→A (Thr431Asn) polymorphism of ROCK2 in individuals with low serum TG; the 734C→T (Thr254Ile) polymorphism of ACAT2 and the C→G (Gln27Glu) polymorphism of ADRB2 in individuals with high serum TG; the -1607/1G→2G polymorphism of MMP1 in individuals with low serum HDL-cholesterol; the G→A (Val158Met) polymorphism of COMT in individuals with low serum LDL-cholesterol; the 584G→A (Gln192Arg) polymorphism of PON1 in individuals with high serum LDLcholesterol. No polymorphism was associated with CKD in individuals with high serum HDL-cholesterol. These results suggest that polymorphisms associated with CKD may differ among individuals with different lipid profiles. Stratification of subjects according to lipid profiles may thus be important for personalized prevention of CKD based on genetic information.
Introduction
Chronic kidney disease (CKD) has been recognized as a global public health problem; individuals with CKD are at an increased risk not only for end-stage renal disease (ESRD), but also for a poor cardiovascular outcome and premature death (1, 2) . CKD is a multifactorial disorder that is thought to result from an interaction between genetic background and environmental factors. Principal and treatable risk factors for CKD include diabetes mellitus (3), glomerular nephritis (4), hypertension (5, 6) , and hyperlipidemia or dyslipidemia (7, 8) . However, the effect of lipid profiles on the development of CKD is controversial given that there are no large studies proving the effect of lipid reduction on the progression of renal disease (9) . Disease prevention is an important strategy for reducing the overall burden of CKD and ESRD, and the identification of markers for disease risk is a key both for risk prediction and for potential intervention to reduce the chance of future cardiovascular events (10) . It is thus important to identify markers that confer susceptibility to CKD in individuals with different lipid profiles independently.
Although genetic linkage analyses (11, 12) and association studies (13, 14) have implicated several loci and candidate genes in predisposition to CKD, the genes that contribute to genetic susceptibility to CKD remain largely unknown. In addition, given the ethnic differences in lifestyle and environmental factors as well as in genetic background, it is important to examine genetic polymorphisms related to CKD in each ethnic group. We hypothesized that the association of gene polymorphisms with CKD might be influenced by baseline lipid profiles. Here, we performed an association study of 296 polymorphisms of 202 candidate genes and CKD in 5944 Japanese individuals with low or high serum concentrations of triglycerides (TG), high-density lipoprotein (HDL)-cholesterol, or low-density lipoprotein (LDL)-cholesterol. The purpose of the present study was to identify genetic variants that confer susceptibility to CKD in individuals with different lipid profiles independently and thereby to assess the genetic risk of CKD in such individuals separately.
Materials and methods
Study population. The study population comprised 5944 unrelated Japanese individuals who either visited outpatient clinics of or were admitted to one of the participating hospitals (Gifu Prefectural General Medical Center and Gifu Prefectural Tajimi Hospital in Gifu Prefecture, Japan; and Hirosaki University Hospital, Reimeikyo Rehabilitation Hospital, and Hirosaki Stroke Center in Aomori Prefecture, Japan) between October 2002 and March 2008 because of various symptoms or for an annual health checkup, or who were recruited to a population-based prospective cohort study of aging and agerelated diseases in Gunma Prefecture and Tokyo, Japan.
The glomerular filtration rate was estimated with the use of the simplified prediction equation derived from the modified version of that described in the Modification of Diet in Renal Disease (MDRD) Study as proposed by the Japanese Society of Nephrology (15) (10) . Nonlinear relations between GFR and the risk of adverse events such as death, cardiovascular events, and hospitalization have been demonstrated, with an increased risk being associated with an eGFR of <60 ml min -1 1.73 m -2 (16) . We thus adopted the criterion of an eGFR of <60 ml min -1 1.73 m -2 for diagnosis of CKD in the present study. On the basis of this criterion, 1706 subjects were diagnosed with CKD. The control subjects comprised 4238 individuals whose eGFR was ≥60 ml min Genotyping of polymorphisms. Venous blood (7 ml) was collected in tubes containing 50 mmol/l ethylenediaminetetraacetic acid (disodium salt), and genomic DNA was isolated with a kit (Genomix; Talent, Trieste, Italy). Genotypes of the 296 polymorphisms were determined at G&G Science (Fukushima, Japan) by a method that combines the polymerase chain reaction (PCR) and sequence-specific oligonucleotide probes with suspension array technology (Luminex, Austin, TX). Detailed genotyping methodology was described previously (17) .
Statistical analysis. Quantitative data were compared between subjects with CKD and controls using the unpaired Student's t-test. Categorical data were compared with the Chi-square test. Allele frequencies were estimated using the gene counting method. In the initial screen, the genotype distributions (3x2) or allele frequencies (2x2) of each polymorphism were compared between subjects with CKD and the controls with the Chi-square test. Polymorphisms related (P-value for allele frequency <0.05) to CKD were further examined by multivariable logistic regression analysis with adjustment for covariates, with CKD as a dependent variable and independent variables including age, gender (0, woman; 1, man), body mass index (BMI), smoking status (0, nonsmoker; 1, smoker), serum concentrations of TG or HDL-or LDLcholesterol, history of hypertension or diabetes mellitus (0, no history; 1, positive history), and genotype of each polymorphism; the P-value, odds ratio and 95% confidence interval were calculated. Each genotype was assessed according to dominant, recessive, and additive genetic models. Additive models included the additive 1 model (heterozygotes versus wild-type homozygotes) and the additive 2 model (variant homozygotes versus wild-type homozygotes), which were analyzed simultaneously with a single statistical model. We also performed a stepwise forward selection procedure to examine the effects of genotypes as well as of other covariates on CKD; each genotype was examined according to a dominant or recessive model on the basis of statistical significance in the multivariable logistic regression analysis. Given the multiple comparisons of genotypes with CKD, we adopted the criterion of a P-value of <0.005 for significant association. For other clinical background data, a P-value <0.05 was considered statistically significant. Statistical significance was examined by two-sided tests performed with JMP version 6.0 software (SAS Institute, Cary, NC).
Results
Polymorphisms related to CKD in individuals with low or high serum concentrations of TG. The characteristics of the subjects with CKD and controls who had low or high serum concentrations of TG are listed in Table I . For individuals with low serum TG, age, the frequency of male subjects, the serum concentration of TG, as well as the prevalence of hypertension, diabetes mellitus, myocardial infarction, and ischemic stroke were greater, whereas the percentage of smokers and the serum concentration of HDL-cholesterol were lower in subjects with CKD than in controls. For individuals with high serum TG, age and the prevalence of hypertension, diabetes mellitus, myocardial infarction, and ischemic stroke were greater, whereas the percentage of smokers and the serum concentration of HDL-cholesterol were lower in subjects with CKD than in controls.
Comparison of allele frequencies with the Chi-square test revealed that nine and seven polymorphisms were related (P<0.05) to CKD in individuals with low or high serum concentrations of TG, respectively (Table II) . Multivariable logistic regression analysis with adjustment for age, gender, BMI, smoking status, serum concentrations of HDL-and LDL-cholesterol, and the prevalence of hypertension and diabetes mellitus revealed that the A→G (Lys45Glu) polymorphism of MMP3 (additive 2 model), the A→G (Glu23Lys) polymorphism of KCNJ11 (recessive and additive 2 models), and the 125592C→A (Thr431Asn) polymorphism of ROCK2 (dominant model) were significantly (P<0.005) associated with CKD in individuals with low serum TG, and that the 1429C→T polymorphism of GNB3 (dominant model), the C→T polymorphism of PTGS1 (additive 2 model), the C→G (Gln27Glu) polymorphism of ADRB2 (dominant model), and the 734C→T (Thr254Ile) polymorphism of ACAT2 (dominant and additive 1 models) were significantly associated with CKD in individuals with high serum TG (Table III) .
A stepwise forward selection procedure was performed to examine the effects of genotypes for the polymorphisms associated with CKD by multivariable logistic regression analysis as well as of age, gender, BMI, smoking status, serum concentrations of HDL-and LDL-cholesterol, and the prevalence of hypertension and diabetes mellitus on CKD (Table IV) . For individuals with low serum TG, age, hypertension, serum HDL-cholesterol, diabetes mellitus, gender, the ROCK2 genotype (dominant model), smoking, and the KCNJ11 genotype (recessive model) were significant (P<0.005) and independent determinants of CKD. For individuals with high serum TG, age, diabetes mellitus, smoking, gender, ADRB2 (dominant model) and ACAT2 Table I . Characteristics of subjects with low or high serum concentrations of triglycerides (TG). 
Quantitative data are the means ± SD. eGFR, estimated glomerular filtration rate. Table II . Genotype distributions of polymorphisms related (allele frequency, P<0.05) to chronic kidney disease (CKD) with low or high serum concentrations of triglycerides (TG) as determined by the Chi-square test. genotypes (dominant model) were significant and independent determinants of CKD.
Polymorphisms related to CKD in individuals with low or high serum concentrations of HDL-cholesterol.
The characteristics of the subjects with CKD and controls who had low or high serum concentrations of HDL-cholesterol are listed in Table V . For individuals with low serum HDL-cholesterol, age and the prevalence of hypertension were greater, whereas BMI and the percentage of smokers were lower in subjects with CKD than in controls. For individuals with high serum HDLcholesterol, age, the frequency of male subjects, and the serum concentrations of TG and LDL-cholesterol, as well as the prevalence of hypertension, diabetes mellitus, myocardial infarction, and ischemic stroke were greater, whereas the percentage of smokers and the serum concentration of HDLcholesterol were lower in subjects with CKD than in controls.
Comparison of allele frequencies with the Chi-square test revealed that seven and five polymorphisms were related (P<0.05) to CKD in individuals with low or high serum concentrations of HDL-cholesterol, respectively (Table VI) . Multivariable logistic regression analysis with adjustment for age, gender, BMI, smoking status, serum concentrations of TG and LDL-cholesterol, and the prevalence of hypertension and diabetes mellitus revealed that the 34C→G (Pro12Ala) polymorphism of PPARG (additive 1 model) and the -1607/ 1G→2G polymorphism of MMP1 (recessive model) were significantly (P<0.005) associated with CKD in individuals with low serum HDL-cholesterol, and that the -519A→G polymorphism of MMP1 (additive 2 model) was significantly associated with CKD in individuals with high serum HDLcholesterol (Table VII) .
A stepwise forward selection procedure was performed to examine the effects of genotypes for the polymorphisms associated with CKD by multivariable logistic regression analysis as well as of age, gender, BMI, smoking status, serum concentrations of TG and LDL-cholesterol, and the prevalence of hypertension and diabetes mellitus on CKD (Table VIII) . For individuals with low serum HDL-cholesterol, age, hypertension, and the MMP1 genotype (recessive model) were significant (P<0.005) and independent determinants of CKD. For individuals with high serum HDL-cholesterol, age, hypertension, diabetes mellitus, gender, and smoking were significant and independent determinants of CKD.
Polymorphisms related to CKD in individuals with low or high serum concentrations of LDL-cholesterol.
The characteristics of the subjects with CKD and controls who had low or high serum concentrations of LDL-cholesterol are listed in Table IX . For individuals with low or high serum LDL-cholesterol, age, the frequency of male subjects, the serum concentration of TG, as well as the prevalence of hypertension, diabetes mellitus, myocardial infarction, and ischemic stroke were greater, whereas the percentage of smokers and the serum concentration of HDL-cholesterol were lower in subjects with CKD than in controls.
Comparison of allele frequencies with the Chi-square test revealed that different sets of four polymorphisms were related (P<0.05) to CKD in individuals with low or high serum concentrations of LDL-cholesterol (Table X) . Multivariable logistic regression analysis with adjustment for age, gender, BMI, smoking status, serum concentrations of TG and HDLcholesterol, and the prevalence of hypertension and diabetes mellitus revealed that the G→A (Val158Met) polymorphism of COMT (dominant and additive 1 models) and the A→G (Lys45Glu) polymorphism of MMP3 (additive 2 model) were significantly (P<0.005) associated with CKD in individuals with low serum LDL-cholesterol, and that the 584G→A Table II . Continued. Table III . Multivariable logistic regression analysis of polymorphisms related to chronic kidney disease with low or high serum concentrations of triglycerides (TG).
- 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, gender, BMI, smoking status, serum concentrations of HDL-and LDLcholesterol, and the prevalence of hypertension and diabetes mellitus. P-values <0.005 are shown in bold.
-
(Gln192Arg) polymorphism of PON1 (dominant model) and the 2583A→G (Ile823Met) polymorphism of ABCA1 (additive 2 model) were significantly associated with CKD in individuals with high serum LDL-cholesterol (Table XI) .
A stepwise forward selection procedure was performed to examine the effects of genotypes for the polymorphisms associated with CKD by multivariable logistic regression analysis as well as of age, gender, BMI, smoking status, serum concentrations of TG and HDL-cholesterol, and the prevalence of hypertension and diabetes mellitus on CKD (Table XII) . For individuals with low serum LDL-cholesterol, age, hypertension, diabetes mellitus, serum HDL-cholesterol, smoking, gender, and the COMT genotype (dominant model) were significant (P<0.005) and independent determinants of CKD. For individuals with high serum LDL-cholesterol, age, serum HDL-cholesterol, the PON1 genotype (dominant model), and smoking were significant and independent determinants of CKD.
Discussion
We examined the possible relations of 296 polymorphisms of 202 candidate genes to the prevalence of CKD in individuals with low or high serum concentrations of TG or HDL-or LDL-cholesterol, given that interactions between gene polymorphisms and lipid profiles may be important in the development of CKD. Our association study with three steps of analysis (Chi-square test, multivariable logistic regression analysis, and stepwise forward selection procedure) revealed that seven different polymorphisms were significantly associated with the prevalence of CKD in individuals with different lipid profiles.
Rho-associated, coiled-coil containing protein kinase (ROCK) 1 and 2 are immediate downstream targets of a small GTP-binding protein RhoA (18) . The ROCKs affect several cellular functions, one of which is cellular contraction, by controlling actin cytoskeletal assembly (19) . The Asn allele of the 125592C→A (Thr431Asn) polymorphism of Table IV . Effects of genotypes and other characteristics on the prevalence of chronic kidney disease with low or high serum concentrations of triglycerides (TG) as determined by a stepwise forward selection procedure. 
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ROCK2 was associated with greater systolic and diastolic blood pressure and systemic vascular resistance (20) . We showed that the 125592C→A (Thr431Asn) polymorphism of ROCK2 was significantly associated with CKD in individuals with a low serum concentration of TG, with the A allele being protective against this condition. Although hypertension has been considered to be a risk factor for newly onset and developing CKD (6), the mechanism of the relation of the ROCK2 polymorphism to CKD remains to be elucidated. Potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) is expressed in pancreatic ß-cells and also in some other tissues, such as skeletal muscle, heart, peripheral nerve, and brain (21) . Almost half of the patients diagnosed with diabetes mellitus before six months of age have a mutation in KCNJ11 (22) . The Lys allele of the Glu23Lys polymorphism of KCNJ11 was shown to be related to an increased risk for type 2 diabetes mellitus in Caucasians (23) . We showed that the A→G (Glu23Lys) polymorphism of KCNJ11 was significantly associated with CKD in individuals with a low serum concentration of TG, with the G allele being protective against this condition, although the mechanism responsible for the association of the G variant with CKD remains unclear.
Adrenergic, ß-2, receptor, surface (ADRB2) plays an important role in regulating cardiac and vascular functions (24) . The Glu variant of the C→G (Gln27Glu) polymorphism of ADRB2 was shown to be related to lower blood pressure in a Japanese population (25) . We showed that the C→G (Gln27Glu) polymorphism of ADRB2 was significantly associated with CKD in individuals with a high serum concentration of TG, with the G allele being protective against this condition. Effects of this polymorphism on the regulation of blood pressure may account for its association with CKD.
Acetyl-Coenzyme A acetyltransferase 2 (ACAT2) is an intracellular cholesterol esterification enzyme and uses cholesterol and fatty acid as its enzymatic substrates (26) . ACAT2 is mainly found in the liver and intestine (27) , the sites where apolipoprotein B-containing lipoproteins are secreted (28) . The Ile allele of the 734C→T (Thr254Ile) polymorphism of ACAT2 was shown to be related to an increased risk for coronary heart disease in a Chinese population (26) . We showed that the 734C→T (Thr254Ile) polymorphism of ACAT2 was significantly associated with CKD in individuals with a high serum concentration of TG, with the T allele being protective against this condition, although the mechanism Table VIII . Effects of genotypes and other characteristics on the prevalence of chronic kidney disease with low or high serum concentrations of HDL-cholesterol as determined by a stepwise forward selection procedure. Table IX . Characteristics of subjects with low or high serum concentrations of LDL-cholesterol. 
- ---------------------------------------------------------------------------------------------------- responsible for the association of the T variant with CKD remains unknown.
Matrix metallopeptidase 1 (MMP1) degrades fibrillar collagens, particularly types I and III, which are resistant to most other proteinases (29) . The 2G allele of the -1607/1G→2G polymorphism of MMP1, which is located in the promoter region of the gene, was shown to be related to increased transcriptional activity (30) . In addition, the -519A→G polymorphism of MMP1 was shown to be related to the risk of myocardial infarction as part of a haplotype (31) and an increased intima-media thickness of the carotid artery in a German population with hypertension (32) . We showed that the -1607/1G→2G polymorphism of MMP1 was significantly associated with CKD in individuals with a low serum concentration of HDL-cholesterol, with the 2G allele being protective against this condition. Effects of this polymorphism on the development of atherosclerosis may account for its association with CKD.
Catechol-O-methyltransferase (COMT) is involved in catechol homeostasis and plays a regulatory role (33) . In addition, COMT is a key enzyme in the degradation of estrogens, which regulate several biological processes involved in the pathogenesis of myocardial infarction (34) . The Met allele of the G→A (Val158Met) polymorphism of COMT was associated with a decreased activity of COMT (35) and was protective against myocardial infarction among Table X . Genotype distributions of polymorphisms related (allele frequency, P<0.05) to chronic kidney disease (CKD) with low or high serum concentrations of LDL-cholesterol as determined by the Chi-square test. 
hypertensive patients (34) . We showed that the G→A (Val158Met) polymorphism of COMT was significantly associated with CKD in individuals with a low serum concentration of LDL-cholesterol, with the A allele representing a risk factor for this condition, although the mechanism responsible for the association of the A variant with CKD remains to be elucidated.
Paraoxonase 1 (PON1) is one of the paraoxonase family involved in protecting LDL from lipid oxidation (36) . Given that paraoxonases have antioxidant activity and that oxidized LDL is a key mediator of atherosclerosis, the paraoxonases have been considered susceptibility genes for coronary heart disease and ischemic stroke (37, 38) . The Arg allele of the 584G→A (Gln192Arg) polymorphism of PON1 was shown to be related to an increased risk of stroke (38) and endothelial dysfunction among normotensive diabetic subjects (39) . We showed that the 584G→A (Gln192Arg) polymorphism of PON1 was significantly associated with CKD in individuals with a high serum concentration of LDL-cholesterol, with the A allele being protective against this condition. The discordant results might be attributed to the stratification of subjects by lipid profiles in the present study.
Our study has several limitations: (i) We used an estimated glomerular filtration rate (eGFR) instead of a directly measured rate to define CKD. (ii) We were not able to obtain information on the underlying renal disease of CKD in each subject with CKD. (iii) Although a previous study (6, 40) showed smoking to be a risk factor for CKD, the frequency of smoking was significantly lower in subjects with CKD than in controls. Selection bias could not be excluded in the present study, given that the subjects were recruited both from patients who visited the hospitals and from communitydwelling individuals. (iv) It is possible that one or more of Table XI . Multivariable logistic regression analysis of polymorphisms related to chronic kidney disease with low or high serum concentrations of LDL-cholesterol.
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the polymorphisms associated with CKD in the present study are in linkage disequilibrium with other polymorphisms in the same gene or in other nearby genes that are actually responsible for the development of this condition. (v) The functional relevance of the identified polymorphisms to gene transcription or to protein function was not determined in the present study. (vi) Although we adopted the criterion of P<0.005 for significant association to compensate for the multiple comparisons of genotypes with CKD, it is not possible to exclude completely potential statistical errors such as false positives.
In conclusion, our present results implicate seven different polymorphisms as being associated with CKD in individuals with low or high serum concentrations of TG or HDL-or LDL-cholesterol. Determination of genotypes for these polymorphisms may prove informative for assessment of the genetic factors for CKD and may contribute to the personalized prevention of this condition. Our present study can be considered as hypothesis generating, and validation of our findings will require their replication with independent subject panels.
